1h Free Analyst Time
The Artificial Intelligence in Diabetes Management Market grew from USD 770.88 million in 2023 to USD 1.00 billion in 2024. It is expected to continue growing at a CAGR of 30.71%, reaching USD 5.02 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
The use of Artificial Intelligence (AI) in diabetes management is transforming the landscape of healthcare through enhanced predictive analysis, efficient disease monitoring, and personalized treatment plans. This emerging field is driven by the need to manage the rising global diabetes prevalence more effectively, offering applications in continuous glucose monitoring, automated data analysis, and predictive analytics to curb disease complications. End-use sectors primarily encompass healthcare providers, research institutions, and pharmaceutical companies that leverage AI technologies to enhance patient outcomes and streamline treatment approaches. The market is propelled by technological advancements in AI algorithms, increased adoption of telehealth services, and a growing demand for personalized medicine. Key growth factors include the rising prevalence of diabetes, increasing healthcare expenditures, and significant investments in AI-driven healthcare solutions. Recent opportunities lie in integrating AI with wearable devices and expanding telemedicine capabilities, providing real-time data for improved decision-making. Market players should focus on developing user-friendly, cost-effective solutions to capitalize on these opportunities effectively. However, limiting factors such as high initial costs, data privacy concerns, regulatory challenges, and the need for extensive clinical validation pose significant hurdles. Overcoming these challenges requires establishing robust data security measures, clear regulatory frameworks, and conducting comprehensive clinical trials for AI tools. Innovations should be directed towards enhancing algorithm accuracy, developing interoperable systems, and minimizing latency in real-time analytics. Businesses can gain a competitive edge by investing in R&D to push these boundaries and by fostering partnerships with tech companies to leverage expertise in data science and AI. The market is highly competitive and fast-evolving, necessitating agility and strategic foresight to harness AI's full potential in diabetes management effectively.
Understanding Market Dynamics in the Artificial Intelligence in Diabetes Management Market
The Artificial Intelligence in Diabetes Management Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Increasing demand for smart glucose monitoring device
- Rising geriatric population and type 2 diabetes patients
- Growing application of AI in diabetes self management
- Market Restraints
- Expensive AI-based medical devices
- Market Opportunities
- Increasing mobile apps to monitor and manage diabetes
- Inclination towards the home care or self-management of diabetes
- Market Challenges
- Lack of awareness among the people
Exploring Porter’s Five Forces for the Artificial Intelligence in Diabetes Management Market
Porter’s Five Forces framework further strengthens the insights of the Artificial Intelligence in Diabetes Management Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Artificial Intelligence in Diabetes Management Market
External macro-environmental factors deeply influence the performance of the Artificial Intelligence in Diabetes Management Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Artificial Intelligence in Diabetes Management Market
The Artificial Intelligence in Diabetes Management Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Artificial Intelligence in Diabetes Management Market
The Artificial Intelligence in Diabetes Management Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Artificial Intelligence in Diabetes Management Market
The Artificial Intelligence in Diabetes Management Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Diabetes Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd., Glooko SAS, HCL Technologies Limited, International Business Machines Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Virta Health Corp., and Vodafone Group PLC.Market Segmentation & Coverage
This research report categorizes the Artificial Intelligence in Diabetes Management Market to forecast the revenues and analyze trends in each of the following sub-markets:- Device
- Diagnostic Devices
- Glucose Monitoring Devices
- Insulin Delivery Devices
- Technique
- Case-Based Reasoning
- Intelligent Data Analysis
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Artificial Intelligence in Diabetes Management Market, by Device
7. Artificial Intelligence in Diabetes Management Market, by Technique
8. Americas Artificial Intelligence in Diabetes Management Market
9. Asia-Pacific Artificial Intelligence in Diabetes Management Market
10. Europe, Middle East & Africa Artificial Intelligence in Diabetes Management Market
11. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Artificial Intelligence in Diabetes Management market, which are profiled in this report, include:- Abbott Laboratories
- Bigfoot Biomedical, Inc.
- Cardinal Health Inc.
- Crayon Group
- DreaMed Diabetes, Ltd.
- Eyenuk, Inc.
- F. Hoffmann-La Roche Ltd.
- Glooko SAS
- HCL Technologies Limited
- International Business Machines Corporation
- Medtronic PLC
- Novo Nordisk A/S
- Sanofi S.A.
- Virta Health Corp.
- Vodafone Group PLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 183 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1 Billion |
| Forecasted Market Value ( USD | $ 5.02 Billion |
| Compound Annual Growth Rate | 30.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
